Cargando…

Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors

BACKGROUND: Psychotropic medication is frequently administered to people with intellectual disability with mental health and/or behavioural problems, instead of other non‐pharmacological interventions. This study describes the mental health and behavioural problems of people aging with intellectual...

Descripción completa

Detalles Bibliográficos
Autores principales: García‐Domínguez, Laura, Navas, Patricia, Verdugo, Miguel Ángel, Arias, Víctor B., Gómez, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545215/
https://www.ncbi.nlm.nih.gov/pubmed/35384179
http://dx.doi.org/10.1111/jar.12996
_version_ 1784804769368375296
author García‐Domínguez, Laura
Navas, Patricia
Verdugo, Miguel Ángel
Arias, Víctor B.
Gómez, Laura E.
author_facet García‐Domínguez, Laura
Navas, Patricia
Verdugo, Miguel Ángel
Arias, Víctor B.
Gómez, Laura E.
author_sort García‐Domínguez, Laura
collection PubMed
description BACKGROUND: Psychotropic medication is frequently administered to people with intellectual disability with mental health and/or behavioural problems, instead of other non‐pharmacological interventions. This study describes the mental health and behavioural problems of people aging with intellectual disability, their psychotropic medication intake, and the factors contributing to a greater medication intake. METHOD: The sample consisted of 991 people with intellectual disability over 45 years. Descriptive statistics and multinominal logistic regression were carried out. RESULTS: Antipsychotics were the most used psychotropic drug. Older people with mild intellectual disability living in institutions and affected by mental health and behavioural problems were more likely to take larger amounts of psychotropic medication. CONCLUSIONS: Antipsychotics continue to be widely used by people with intellectual disability and mental and behavioural health problems, especially those in institutionalised settings. Future research should consider if medication intake could be reduced providing better supports in the community and non‐pharmacological interventions.
format Online
Article
Text
id pubmed-9545215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-95452152022-10-14 Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors García‐Domínguez, Laura Navas, Patricia Verdugo, Miguel Ángel Arias, Víctor B. Gómez, Laura E. J Appl Res Intellect Disabil Original Articles BACKGROUND: Psychotropic medication is frequently administered to people with intellectual disability with mental health and/or behavioural problems, instead of other non‐pharmacological interventions. This study describes the mental health and behavioural problems of people aging with intellectual disability, their psychotropic medication intake, and the factors contributing to a greater medication intake. METHOD: The sample consisted of 991 people with intellectual disability over 45 years. Descriptive statistics and multinominal logistic regression were carried out. RESULTS: Antipsychotics were the most used psychotropic drug. Older people with mild intellectual disability living in institutions and affected by mental health and behavioural problems were more likely to take larger amounts of psychotropic medication. CONCLUSIONS: Antipsychotics continue to be widely used by people with intellectual disability and mental and behavioural health problems, especially those in institutionalised settings. Future research should consider if medication intake could be reduced providing better supports in the community and non‐pharmacological interventions. Blackwell Publishing Ltd 2022-04-05 2022-09 /pmc/articles/PMC9545215/ /pubmed/35384179 http://dx.doi.org/10.1111/jar.12996 Text en © 2022 The Authors. Journal of Applied Research in Intellectual Disabilities published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
García‐Domínguez, Laura
Navas, Patricia
Verdugo, Miguel Ángel
Arias, Víctor B.
Gómez, Laura E.
Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
title Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
title_full Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
title_fullStr Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
title_full_unstemmed Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
title_short Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
title_sort psychotropic drugs intake in people aging with intellectual disability: prevalence and predictors
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545215/
https://www.ncbi.nlm.nih.gov/pubmed/35384179
http://dx.doi.org/10.1111/jar.12996
work_keys_str_mv AT garciadominguezlaura psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors
AT navaspatricia psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors
AT verdugomiguelangel psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors
AT ariasvictorb psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors
AT gomezlaurae psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors